https://cannabisexaminers.com/wp-content/uploads/2019/02/4028/investing-in-the-biotechnology-of-cannabis.jpg
Four world leaders in the clinical applications of cannabis take a deep dive into cannabinoid based drugs, IP, and the biotechnology of cannabis.
Panelists:
Matthew Callhan – Botanix Pharmaceuticals
Guy Chamberland – Tetra Bio-Pharma
John Docherty – Lexaria Biosciences
David Elsley – Cardiol Therapeutics
Moderated by Rahul Sarugaser – Paradigm Capital
Join us at an upcoming event! http://www.cambridgehouse.com
Be part of our investment community:
http://www.cambridgehouse.com/
https://twitter.com/cambridge
https://www.facebook.com/cambridgehouseconferences
https://www.linkedin.com/company/cambridge-house-international/
Copyright © 2019 Cambridge House International Inc. All rights reserved.
About C.E. News
